Fidelity's $1.96 Trillion Q4 2025 Filing Puts 9.2% Into NVIDIA — the Biggest Active Overweight Among Mega-Managers
FMR LLC's Q4 2025 13F shows $1.96T with NVDA at 9.23% — over 3 percentage points above index weight. Unlike passive peers, Fidelity's filing reveals genuine active conviction in the AI trade.
FMR LLC (Fidelity Investments) filed its Q4 2025 13F with $1.96 trillion across 13,225 positions. The standout: NVIDIA (NVDA) at 9.23% of the portfolio — more than 3 percentage points above where passive index funds hold it.
TL;DR
- Total 13F AUM: $1.96 trillion (up 2.0% from $1.92T in Q3)
- Positions: 13,225 (up from 13,217 in Q3)
- NVDA weight: 9.23% ($181.1B) — vs 6.13% at Vanguard/BlackRock
- Top-3 concentration: 18.4% (NVDA + MSFT + AAPL)
- Active overweight: NVDA +3.1pp, META +2.2pp vs cap-weight
- Notable underweight: AAPL at 4.26% vs 5.5%+ at passive peers
- Key signal: Fidelity is the only mega-manager running a meaningful NVDA overweight
Fidelity (FMR) Top 10 Holdings — Q4 2025 ($B)
The Active Tilt: NVDA at 9.2%
Among managers with $1T+ in 13F AUM, Fidelity’s 9.23% NVDA allocation stands alone. Vanguard, BlackRock, and State Street all hold NVDA near 6.1-6.2% — roughly market-cap weight. Fidelity’s extra 3 percentage points represents about $60 billion in deliberate NVDA overweight.
This isn’t accidental. Fidelity runs significant actively managed funds alongside its index products, and the aggregate 13F reveals their collective conviction in the AI infrastructure trade.
Top Holdings Reveal Active Choices
| Rank | Ticker | Value | Weight | vs Index |
|---|---|---|---|---|
| 1 | NVDA | $181.1B | 9.23% | +3.1pp |
| 2 | MSFT | $97.2B | 4.96% | ~flat |
| 3 | AAPL | $83.6B | 4.26% | -1.3pp |
| 4 | META | $80.8B | 4.12% | +2.2pp |
| 5 | AMZN | $76.5B | 3.90% | +1.0pp |
| 6 | GOOGL | $72.6B | 3.70% | +1.3pp |
| 7 | AVGO | $42.6B | 2.17% | ~flat |
| 8 | GOOG | $34.2B | 1.74% | ~flat |
| 9 | LLY | $27.6B | 1.41% | ~flat |
| 10 | TSM | $18.6B | 0.95% | N/A (ADR) |
Three things stand out: (1) NVDA massively overweight, (2) AAPL meaningfully underweight at 4.26% vs 5.5%+ at peers, (3) META overweight at 4.12% vs ~1.9% at passive managers. Fidelity is clearly tilting toward AI infrastructure (NVDA) and AI applications (META) while trimming the legacy hardware giant (AAPL).
Fidelity (FMR) AUM History (2024-2025)
AUM Growth: Steady but Below Peers
Fidelity’s 13F AUM grew from $1.64T (Q3 2024) to $1.96T (Q4 2025), a 19.4% gain over six quarters. This trails Vanguard (+23.5%) and BlackRock (+24.2%) over the same period, partly reflecting Fidelity’s larger allocation to non-13F assets like bonds and alternatives.
What Analysts Might Misread
“Fidelity is betting the firm on NVDA.” The 9.23% is an aggregate across hundreds of funds, not a single concentrated bet. Some Fidelity funds will hold NVDA at 15%+ while others may hold zero. The aggregate reflects a broad institutional tilt, not a single manager’s conviction.
“Fidelity is bearish on Apple.” A 4.26% AAPL weight still represents $83.6 billion in Apple stock. The underweight relative to index is notable but not a bearish signal — it reflects Fidelity’s active funds choosing to deploy capital elsewhere.
Why does Fidelity hold more NVDA than index funds?
Fidelity manages both index and actively managed funds. The active funds collectively overweight NVDA based on fundamental views about AI demand, which pushes the aggregate 13F weight above market-cap proportion.
Is Fidelity’s AAPL underweight significant?
Yes. At 4.26%, Fidelity holds about 1.3 percentage points less Apple than passive peers (5.5%+). This represents roughly $25 billion in “missing” Apple allocation that’s been redirected primarily to NVDA and META.
Related Research
Explore all researchUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reported $472.97B for 2025Q4, with NVDA at 8.13% and top-5 concentration at 27.42%.
Mar 23, 2026
National Pension Service reported $135.07B for 2025Q4, with NVDA at 6.92% and top-5 concentration at 24.48%.
Mar 23, 2026
Mitsubishi UFJ Asset Management Co., Ltd. reported $147.50B for 2025Q4, with NVDA at 6.85% and top-5 concentration at 25.68%.
Mar 23, 2026
Sumitomo Mitsui Trust Group, Inc. reported $170.27B for 2025Q4, with NVDA at 7.17% and top-5 concentration at 24.74%.
Mar 23, 2026
Diesslin Group, Inc. reported $251.64M for 2025Q4, with BRK/B at 23.93% and top-5 concentration at 66.61%.
Mar 23, 2026